Maravai LifeSciences Holdings Inc. Class A Common Stock vs Star Bulk Carriers Corp — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while Star Bulk Carriers Corp trades at $28.76 (market cap $3.46B). The key difference: Star Bulk Carriers Corp is far larger — about 3.6× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Star Bulk Carriers Corp pays a 6.31% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Star Bulk Carriers Corp for 23 Days on average.
| MRVI | SBLK | |
|---|---|---|
Market Cap | $972.90M | $3.46B |
Volume | 4,325,710 | 1,078,337 |
Sector | Health | Industrials |
52-Week High | $9.00 | $32.49 |
52-Week Low | $2.83 | $17.42 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $1.08B | $4.14B |
Dividend Yield | — | 6.31% |
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Star Bulk Carriers (SBLK) trades at $29.79, down 0.17% with a bearish technical signal despite strong fundamentals. The company demonstrates robust profitability with 23.87% net income margin and has beaten earnings estimates for three consecutive quarters. Recent insider buying activity and a 58.34% analyst buy rating signal confidence, while the stock offers an attractive valuation with P/E of 11.68 and upcoming $0.90 dividend payment.
SBLK presents a compelling value opportunity with strong earnings momentum and shareholder returns, though technical weakness and shipping sector volatility pose near-term risks. The company's 100% free cash flow distribution policy and projected revenue growth to $1.2B in 2026 support the bullish fundamental case, while bearish moving averages suggest potential consolidation before further upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →